Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived

Author： O’Neil Bert H   Goldberg Richard M  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.12, 2003-12, pp. : 1939-1949

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel agents for colorectal cancer

By Royce M.E.   Pazdur R.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1639-1652

Informa Healthcare

Access to resources Recommend Favorite

Novel chemotherapeutic agents for the treatment of brain cancer

By Newton H.B.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2815-2829

Informa Healthcare

Access to resources Recommend Favorite

Novel and Emerging Targeted Therapies of Colorectal Cancer

By  

Current Clinical Pharmacology, Vol. 10, Iss. 4, 2015-10 ,pp. : 279-298

Bentham Science Publishers

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite

Hsp90 Inhibitor Geldanamycin and Its Derivatives as Novel Cancer Chemotherapeutic Agents

By  

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1131-1138

Bentham Science Publishers

Access to resources Recommend Favorite